Cervical cancer is a significant health concern worldwide, and early detection is critical to improving outcomes. We had the opportunity to sit down with Nutte van Belzen, MD, the visionary behind CC Diagnostics, to discuss his company’s groundbreaking approach to cervical cancer diagnostics and the journey that led to its inception.

The Oct. 31st Tech4Eva Roadshow brought together industry leaders, innovators, and experts who learned how to support women’s health in the workplace to have higher productivity, better retention of female employees and help improve health outcome for women.

Menopause is often seen as a silent milestone, but its impact on women’s health is profound and long-lasting. More than just the end of reproductive years, menopause influences everything from heart health and bone strength to mental wellbeing and productivity. Yet, for many, it remains a misunderstood and stigmatized topic. Discover SinReglas, a start-up which is changing the narrative. Menopause is not anymore something to endure in silence — it's an opportunity to take control, make informed choices, and thrive.

Can a simple shift in how we approach preterm birth prevention save millions of lives? Discover Galena Innovations, which is developing the Hannah Cervical Cup, the solution to spontaneous preterm birth. Their mission is to change the trajectory of obstetrics from stagnation to innovation by creating solutions that meet the needs of mothers everywhere, from Mississippi to Malawi, ending the health and social inequities that are pervasive in our world, beginning with birth.

The Tech4Eva Roadshow, in partnership with Promotion Santé Suisse, recently brought together decision-makers, business leaders, Human Resource Managers, DEI specialists, and Workplace Health professionals to explore the critical intersection of women’s health and business performance.

Harmonia Healthcare is a highly specialized women’s health platform that combines cutting-edge, functional medical treatment with science-backed research for underdiagnosed, undertreated, and otherwise dismissed female-specific diseases.

Calico Biosystems is addressing the critical unmet need of the poor efficacy of cancer therapeutics for female patients with cancers.

Endometriosis is a chronic disease affecting 10% of women of reproductive age. The lack of objective diagnostic tools leads to delayed diagnosis, allowing the disease to progress. Current imaging techniques fail to detect most endometriosis lesions, leaving disease management blind to lesion locations, dimensions, and stages. EndoCure offers an advanced system for the detection, mapping, and staging of lesions through robotic AI-powered 3D ultrasound imaging. Their solution provides the first complete map of lesions, enabling physicians to determine disease stages and tailor appropriate treatments.

Cosm Medical is modernizing pelvic health through precision gynecological devices to improve the lives of individuals suffering from common and underserved pelvic health issues.

CareNX has developed SinDiColpo, a low-cost, point-of-care device for cervical cancer screening. This battery-operated and AI-enabled device is patented and has demonstrated 100% sensitivity in controlled studies when compared to the gold standard histopathology.

Namida Lab, founded by Omid Moghadam, is a biotechnology start-up that specializes in developing early cancer detection tests using proteomics.

Hormona is an all-in-one companion for your hormone health and was founded in 2023 by Karolina Löfqvist and Jasmine Tagesson. Take control with Hormona and learn how the company was created and how they tackle this industry sector.

Tech4Eva is happy to announce a strategic partnership with Debiotech, a leading service development company dedicated to innovation in medical technology for over 30 years.

The Tech4Eva Opening Conference brought together 250+ Femtech stakeholders in the ecosystem and celebrated the 17 selected start-ups of the 2024 program and the Debiotech Prize Winner.

Tech4Eva, is entering its fourth round with another record number of 189 applications. In its 2024 edition, the start-up acceleration program of Groupe Mutuel and the EPFL Innovation Park is supporting 17 start-ups from a wide range of fields, such as Menstrual & Maternal health, reproductive medicine, wellbeing or oncology for women. Among them are 2 start-ups from Switzerland.

LumaWomb is the first of its kind, bridging the gap between a holistic approach and medical scientifically driven fertility assistance.

The start of a partnership with Amboy Street Ventures.

New partnership with Business Angels Switzerland (BAS), a leading network of individual investors committed to fostering innovation and driving growth in the Swiss start-up ecosystem

Calling all Femtech pioneers ! Join our 2024 Accelerator Program to reshape women's health. 🚀

In the intricate tapestry of women's health, one often overlooked issue is pelvic floor dysfunction. A prevalent issue affecting one in three women, this silent struggle encompasses challenges such as urinary incontinence, pelvic organ prolapses, and chronic discomfort. These issues transcend age, affecting women across various stages of life, from childbirth to ageing. The awakening to the profound impact on daily lives and mental wellbeing has given rise to innovative solutions, with WakeUp Pelvic at the forefront.

It’s a wrap of the 2023 Tech4Eva program and its 3rd annual hybrid conference which took place on November 30th once again to celebrate the founders who revolutionize women's healthcare with their solutions. The conference brought together 400 stakeholders including corporate experts, entrepreneurs, innovators, academic researchers, as well as ecosystem builders to discuss the future of women’s health. It was fantastic to connect with some of the founders in person and to see so many of you gathered online from around the world.

The FemTech sector is growing worldwide. According to a study by the strategy consultancy Boston Consulting Group (BCG), the number of FemTech providers has doubled since 2015, rising from 600 in 2015 to 1,300 companies in 2022. In Switzerland too, women's specific health has arrived on the market. Companies are supported by the FemTech start-up accelerator Tech4Eva, which is concluding its third edition this week.

In the ever-evolving landscape of women's health and technology, the Tech4Eva Boston Roadshow 2023 emerged as a pivotal event, unraveling insights and perspectives that shape the future of Femtech.

RU Medical, co-founded by Nitya Dintakurti is on a mission to revolutionize menopausal care. This committed team spans two nations, the UK and India, and is highly diverse in terms of culture and experience.

The Tech4Eva India Roadshow took place on October 10th and highlighted the local ecosystem, challenges, and opportunities. The Femtech industry in India is new but gaining popularity and investment. The Indian Femtech market is expected to reach $4 billion by 2024, with a CAGR of 12.9% and the country has seen a rise in Femtech start-ups addressing various women's health issues like menstrual health, fertility, maternal health, sexual wellness, and mental health.

In a world where IVF success is more efficient and accessible, Manina Medtech is turning its vision into reality with its product “Seedchrony”. This innovative product aims to improve the success rates of In Vitro Fertilization (IVF) by addressing the uncertainty surrounding uterine readiness for embryo transfer, potentially reducing the need for multiple IVF cycles.

One woman in 8 is affected by breast cancer. Today, the most effective way of combating the mortality associated with this disease is early detection. And, Predilife’s solution works effectively in this direction.

This year’s hybrid Tel Aviv Roadshow gathered both the local Israeli Femtech ecosystem of innovators, corporates, and investors along with the global Tech4Eva community. The 2023 Tech4Eva cohort was showcased to potential partners and investors. Are you interested in investing in women’s health solutions or partnering, see more info here.

Tom Devlin’s wife, a journalist, was one day covering topics like gender equity and period poverty. A particular line in her article struck her – "period products should be as ubiquitous as toilet paper." And that is where it all started: This inspired the idea to create a product resembling toilet paper for periods.

In the healthcare landscape where technology is unlocking solutions to change lives of millions, Neuraura made itself a name in the bioelectric medicine industry. Founded by Claire Dixon and Pierre Wijdenes, the company's mission is to transform the standard of care for underserved health conditions through bioelectronic medicine. Neuraura's latest innovation to be introduced is LoOoP, a solution set to be the first effective and widely accessible remedy for PCOS (polycystic ovarian syndrome).

Palpa's device serves as a massager and soap dispenser in the shower, and also allows women to familiarize themselves with the feel of a tumor and incorporate breast self-examination into their daily routines.

Adira empowers pregnant women suffering from high blood pressure, measuring their vitals, assessing their physical and mental wellbeing to provide real-time, data-informed guidance, through our blended maternity care pathway.

While the biotech industry is experiencing a boom in genetic analyses, Beyond Genomix gives individuals easy access to genetic studies and customizes their treatments based on their profiles.

MIM Fertility aims to provide clinicians with the most efficient and safest machine learning technology, remaining at the forefront of scientific research in this field. The team builds AI models and algorithms that help fertility clinics predict and recommend treatments for patients, helping them achieve successful pregnancies. 

With expertise in bioelectronics and medical devices, the co-founders' Rick Rowan and Chloe Stockwell-Clark have developed Mihba, an effective, drug-free, and non-invasive treatment for female health conditions with an initial focus on menstrual health.

Hyivy - the first holistic device that treats, monitors, tracks, and prevents various pelvic symptoms 1 in 3 women experience in their lifetime.

On your way to a healthier mind! With the first-ever neuro-metabolic assessment and innovative neuro-nutrient interventions, HEALTHY-LONGER is targeting the root cause of mental health issues: neuro-nutrient deficiencies.

Hale is a Femtech Platform helping women with chronic pelvic pain, such as endometriosis or vulvodynia, to improve their quality of life, with tailored home care.

Samphire Neuroscience improves women's mental health with a drug-free solution to PMS/PMDD and menstrual pain. Co-founder Emile Radyté prioritizes customer engagement to overcome industry challenges and predicts the development of diverse solutions tailored to women's specific needs. With the launch of their headband at the end of 2023 or early 2024, Samphire Neuroscience is heading to a great future!

Building on the success of its first two years, Tech4Eva unveiled its 2023 Start-up cohort on March 14th. 21 Femtech start-ups from 12 countries coming from a pool of 147 applications from Switzerland and around the world were selected.

Tech4Eva has seen a record number of start-ups applying to participate in its third season. The 2023 program attracted 147 projects from 40 countries, an increase of 18.5% compared with the second edition and 33.6% compared with the first. The 21 start-ups selected for the current program come from 12 different countries.

Roche is dedicated to enhancing women's health by focusing on unmet needs and advancing innovations.

Men and women are different regarding disease risk, frequency, severity, symptomatology, diagnostic journey, and even response to treatment. Read more about how to bring new treatment options to patients and caregivers.

Menopause is currently a hot topic in the workplace, as it can affect how women feel about themselves and their productivity. Menopause is a life phase which affects 50% of the population who have no choice but to go through it and according to Forbes, lost productivity associated with menopause costs $810 billion per year globally.

diaPatchTM is a novel patent-pending molecular diagnostic medical device. This diagnostic patch is non-invasive and able to detect high-risk, pre-cancerous biomarkers more accurately.

By now, most employers know that a healthy workforce is happier, and more productive with less absenteeism and lower healthcare costs. COVID19 has heightened general health concerns and raised awareness of the importance of investing in employee health and resilience more than ever. So where do we start and what matters as the clock ticks to end 2022 and wake-up 2023?

It’s a wrap of the 2022 Tech4Eva program and its 2nd annual hybrid conference which took place on November 28th once again to celebrate the cause to support advancements in Women's Healthcare. The conference brought together 300+ stakeholders, entrepreneurs, innovators, academic researchers, as well as ecosystem builders to discuss the future of women’s health. It was fantastic to connect with some of the founders in person and to see so many of you gathered online as well.

The second edition of Tech4Eva, a unique innovation platform and FemTech acceleration programme in Switzerland, was a great success. The Conference 2022 will discuss how gender medicine and women's health in the workplace are under-exploited.

The Boston innovation system is unique in that there is a significant collaborative presence by governments and regulatory authorities, R&D institutions, hospitals, entrepreneurs, and venture capital.

Digital health solutions promise to deliver value across the healthcare lifecycle: From AI assisted drug development to empowering patients to manage their treatments.

At Tech4Eva Basel Roadshow in partnership with DayOne, the Healthcare Innovation initiative powered by Basel Area Business & Innovation we heard insights about the digital health trends in Switzerland from PwC, pitches from Tech4Eva’s growth start-up and a panel on: “Corporate Collaboration with Start-ups” and a fireside chat about the “Journey of Fundraising”.

Wild.AI is the performance platform for women. Helping to optimize their performance by providing personalized recommendations on how to train, fuel and recover around their life stages.

At the Tech4Eva London Roadshow in partnership with the Embassy of Switzerland in the UK we had the opportunity to meet investors, experts, and leaders in the healthcare field, hear pitches from Tech4Eva’s growth start-up and got insights from two interesting panels on the topics of: “Answering the unmet needs in women’s health” & “Building a successful Femtech company”.

The Start-up focused on Providing Actionable Diagnostics for Women’s Health.

Because each person is unique, so are their temperature needs. Moona learns by your side, night after night, in order to adapt its recommendations and offer you the sleep you deserve. We recently interviewed Co-Founder and CEO of Moona, David Stoikovitch.

Oxidative stress is the disturbance in the balance between the production of free radicals and antioxidant defences. Concerning fertility, it is a powerful bio-marker of embryo viability. With their system Fertissimo, they can also examine multiple embryos in parallel, without disrupting an embryo. Analysis time is extremely short, taking no more than ten minutes for each embryo.

Vyld is here to establish the controlled cultivation of algae as a marine conservation measure by harnessing seaweed as a sustainable material for everyday products, such as tampons, diapers, or cotton wool.

Hashiona is the first mobile application dedicated to people with Hashimoto’s disease and/or hypothyroidism. It tracks your symptoms regularly as well as your diet and lifestyle and get your life back!

Preterm birth still is one of the biggest challenges in modern obstetrics. Very often pregnant women and clinicians are left with no reliable information about their risk for delivering preterm. Pregnolia is measuring cervical stiffness – A world first in pregnancy care!

Susan Herbert, who is the Global Head of Strategic Excellence at Merck has been supporting Tech4Eva’s start-ups since its inception in 2021 and she gives us a few insights on how to work with corporates.

Tech4Eva mentor, Alice Zheng, Principal at RH Capital, recently co-authored a few research articles on women’s health innovation trends and opportunities. We sat down with her to hear more - rationale, highlights and a roadmap moving forward.

Dr. Amy Beckley is co-founder of Proov, a leading system to evaluate women's hormones. She kindly took the time to answer our questions about her background and her startup main goals.

For this year’s Swiss-Korean Innovation Week on the theme of “diversity”. This event aimed to raise awareness on themes directly connected to the women wellbeing with a reference to the cultural context in Korea.

The mission of this industry goes much beyond providing solutions to women health’s challenges, it exists to break taboos and step change the role of women in our society.

The event brought together INSEAD MBA students, start-ups, investors and experts to discuss how technology can help us improve healthcare and how digital innovation specifically can empower healthcare.

Dana focuses on providing holistic solutions (mind, body, and heart) to enable the best start in life by maximizing the health and wellbeing of the mothers and their children.

RH Capital seeks to leverage venture capital as a tool to maximize public health impact along with financial returns when investing in innovations that serve the global market while including health equity directly in their investment strategy.

b-rayZ offers a revolutionary AI platform that for the first time allows personalized, flowless and sustainable diagnostics of breast cancer. The solution relies on the newest AI architectures that reveal complex patterns in medical images.

Essity joined the Tech4Eva initiative in 2022 with Kai Thornagel as a mentor to the growth stage start-ups. Essity Ventures connects the dots between innovation and expertise to revolutionize the future of health and hygiene.

Tech4Eva kicks off with a big bang on March 31st to celebrate the revealing of it's 2022 Start-up cohort!

‍124 start-ups from 30 countries have applied to take part in the second edition of Tech4Eva, the unique accelerator for FemTech start-ups in Switzerland.

With years of expertise in MedTech development, CSEM will capitalize on its wealth of knowledge to help bolster the impact of the initiative in the global FemTech community.

Metabolomic Diagnostics is a deep-tech start-up specializing in developing innovative biomarker-based diagnostic solutions for complex diseases. The current and primary focus of the company is screening for preeclampsia, as identifying women at risk of this terrible condition is an unmet clinical need.

A good treatment starts with an excellent diagnosis, which is precisely the mission of GYNTOOLS. It offers an automated device dedicated to providing excellent diagnostics for both infectious and non-infectious potential conditions of vaginitis.

Tech4Eva Conference 2021 brought together the Femtech community and shed light on the field of women's health research, focusing on topics such as: Building inefficiencies of IVF Treatment; Streamlining point of care diagnostics & trends; How host reproductive status shapes the vaginal ecosystem; Economic impact of menopause in the workplace; Trends in psychological wellbeing & women’s health and Bringing Women’s health innovation to market as well as celebrated the success of the 1st cohort.

Aspivix is a women's healthcare start-up focused on gynecology. The team focuses on reducing pain caused by procedures affecting 90 million women every year.

Yonicore is a holistic solution for pelvic floor dysfunctions. Learn about the wearable device that offers women an immediate solution, which is non-invasive.

Assembling and analyzing information about 85 organizations related to the Swiss FemTech market, including 33 companies, 15 nonprofits, and 37 investors considered by sectors, the research shed light on key features, trends, industry innovations, technologies, market segmentation, and perspective.

The first edition of Tech4Eva, a FemTech innovation platform and start-up accelerator unique in Switzerland, has proved to be a huge success. Tech4Eva is the result of a partnership launched in 2021 between Groupe Mutuel and EPFL Innovation Park to promote new technologies and solutions for women's health. Start-ups participating in the FemTech accelerator Tech4Eva raise CHF 60 million for women's health.

Boston Roadshow 2021 shed light on the field of women's health research in the United States, focusing on past policies, current practices, and the processes that will lead us to a better gender-equity future. Women are still under-represented in clinical trials compared to men. Founders also highlighted the different ways of approaching investors and the exit strategies to consider to be aligned with their investors.

The Swiss investment community is not just growing, is becoming internationally known. With more players in the space, there is more variety of investment sizes available for a wider range of companies in various sectors. This growth has created an active ground for health-tech companies successfully raising in 2020 and 2021.

On September 22nd, Tech4Eva made a great debut at London Tech Week. The third Roadshow of 2021 gathered investors, entrepreneurs, health industry leaders, and NHS experts to discuss the opportunities and key partnerships to scale femtech start-ups in the UK. 

Sexually transmitted diseases (STDs) are taboo, there is fear in getting tested and shame in contracting them and people in general know very little about them. Testmate aims to break the stigma and raise awareness while providing an accessible and easy-to-use solution.

This in-depth analysis of the trends and developments of the FemTech industry is built on data from 1550 FemTech companies, 1000 investors in this sector, and 30 laboratories and R&D centres.

Swiss-based biotech start-up, MUVON Therapeutics, is bringing cutting-edge cell therapy research to life for the regeneration of skeletal muscle tissue.

Isma Hachi, PhD, Senior Manager in Life Sciences Consulting at PwC Switzerland, presents an overview of the Global top health industry issues 2021 and their impact on the FemTech sector.

The Digital health revolution gives FemTech momentum at Tech4Eva Zurich Roadshow Corporate and health systems representatives, investors and FemTech innovators discuss investment opportunities and health trends in digital health.

Tech4Eva welcomes its partner The Embassy of Switzerland in the UK.

Tech4Eva launched the first Roadshow in Tokyo, welcoming FemTech experts, Japanese investors, corporates and start-ups for a joint discussion on the Swiss and the Japanese FemTech ecosystem. 

Tomoko Minagawa from Global Brain Corporation gives an overview of the Japanese market.

Innovative breath analysis tracker by Carbomed Medical Solutions is disrupting the fertility sector.

The inaugural program received over 100 early and growth stage start-ups applications from around the globe - 33 of those are Swiss-based - 77 of which are led by women founders.

Women of Wearables (Wow) is joining as a Program Partner of the Tech4Eva program, offering support to our participants in order to create more impact for the global Femtech community.

Tech4Eva is pleased to share the new partnership with Joyance Partners that will join the program supporting the development of the participating companies and early-stage projects. 

Tech4Eva, is thrilled to announce that Fermata will be joining as a Program partner of the program supporting the participants’ innovation and technology development by providing them visibility into Asian markets.

L’EPFL et le Groupe Mutuel s’unissent pour lancer Tech4Eva, un accélérateur de start-ups unique en Suisse et dédié aux FemTech.

Am heutigen Weltfrauentag bündeln die Groupe Mutuel und der EPFLInnovation Park ihre Kräfte, um neue Technologien für die Gesundheit der Frau zu fördern. DerEPFL Innovation Park und die Groupe Mutuel sind eine Partnerschaft eingegangen und lancierenTech4Eva, einen Start-up Accelerator im Bereich der FemTech. Eine Premiere in der Schweiz.

The EPFL and Groupe Mutuel are joining forces to launch Tech4Eva, a unique acceleration programme in Switzerland for FemTech start-ups.